Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND).

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. A Novel Intronic Mutation in MBD5 Results in Autosomal Dominant Intellectual Disability Type 1 due to Abnormal Splicing.Molecular genetics & genomic medicine · 2025
   Article
2. Transcriptome analysis of MBD5-associated neurodevelopmental disorder (MAND) neural progenitor cells reveals dysregulation of autism-associated genes.Scientific reports · 2021
   Article
3. Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction.BMC medical genomics · 2018
   Article
4. Inherited 2q23.1 microdeletions involving theMolecular genetics & genomic medicine · 2017
   Article

Corrections and comments

• Erratum for
  Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND).2016

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.